SRL
BDMD

Scientech Research LLC’s Baird Medical Investment Holdings BDMD Stock Holding History

Scientech Research LLC’s Portfolio BDMD Stock Details BDMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55,453
Closed -$421K – 876
2024
Q4 		$421K Buy
+55,453
New +$153K 0.12% 348

Other funds holding BDMD

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scientech Research LLC's BDMD Position: Q1 2025 in Review

Scientech Research LLC sold out of Baird Medical Investment Holdings (BDMD) in Q1 2025, closing a stake of 55,453 shares — an estimated $421K sold.

Scientech Research LLC first reported a position in BDMD in Q4 2024 and held it in 1 quarter. The position peaked at $421K in Q4 2024. 6 funds tracked by Wall St. Rank hold BDMD as of Q1 2025.

  • Scientech Research LLC reported no remaining Baird Medical Investment Holdings position as of Q1 2025 after selling out during the quarter.
  • Scientech Research LLC sold 55,453 Baird Medical Investment Holdings shares in Q1 2025, an estimated $421K.
  • Scientech Research LLC first reported a position in Baird Medical Investment Holdings in Q4 2024 and held it in 1 quarter.
  • Scientech Research LLC's Baird Medical Investment Holdings position peaked at $421K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2025.

Based on Scientech Research LLC's 13F filing for Q1 2025, filed 15 May 2025.